Cyclooxygenase as a Target in Lung Cancer

Preclinical studies suggest that cyclooxygenase (COX)-2 may be involved in the molecular pathogenesis of some types of lung cancer. Most of the available studies point to its involvement in non-small cell lung cancer. Survival of patients with non-small cell lung cancer expressing high levels of COX...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical cancer research 2004-06, Vol.10 (12), p.4266s-4269s
Hauptverfasser:	BROWN, Joanne R, DUBOIS, Raymond N
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic agents Biological and medical sciences Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - enzymology Carcinoma, Non-Small-Cell Lung - prevention & control Clinical Trials as Topic Cyclooxygenase 2 Cyclooxygenase 2 Inhibitors Cyclooxygenase Inhibitors - pharmacology Cyclooxygenase Inhibitors - therapeutic use Disease Progression Humans Inflammation Isoenzymes - pharmacology Lung Neoplasms - drug therapy Lung Neoplasms - enzymology Lung Neoplasms - prevention & control Medical sciences Membrane Proteins Neovascularization, Pathologic Pharmacology. Drug treatments Prostaglandin-Endoperoxide Synthases - pharmacology Prostaglandins - pharmacology Survival Analysis Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!